547 related articles for article (PubMed ID: 35563692)
21. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
Nawaito SA; Sahadevan P; Clavet-Lanthier MÉ; Pouliot P; Sahmi F; Shi Y; Gillis MA; Lesage F; Gaestel M; Sirois MG; Calderone A; Tardif JC; Allen BG
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1281-H1296. PubMed ID: 30901279
[TBL] [Abstract][Full Text] [Related]
22. Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
Humeres C; Shinde AV; Hanna A; Alex L; Hernández SC; Li R; Chen B; Conway SJ; Frangogiannis NG
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34905511
[TBL] [Abstract][Full Text] [Related]
23. The plating of rat scar myofibroblasts on matrigel unmasks a novel phenotype; the self assembly of lumen-like structures.
El-Helou V; Gosselin H; Villeneuve L; Calderone A
J Cell Biochem; 2012 Jul; 113(7):2442-50. PubMed ID: 22573558
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.
Tillmanns J; Hoffmann D; Habbaba Y; Schmitto JD; Sedding D; Fraccarollo D; Galuppo P; Bauersachs J
J Mol Cell Cardiol; 2015 Oct; 87():194-203. PubMed ID: 26319660
[TBL] [Abstract][Full Text] [Related]
25. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
Bujak M; Ren G; Kweon HJ; Dobaczewski M; Reddy A; Taffet G; Wang XF; Frangogiannis NG
Circulation; 2007 Nov; 116(19):2127-38. PubMed ID: 17967775
[TBL] [Abstract][Full Text] [Related]
26. Infarct scar: a dynamic tissue.
Sun Y; Weber KT
Cardiovasc Res; 2000 May; 46(2):250-6. PubMed ID: 10773228
[TBL] [Abstract][Full Text] [Related]
27. Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype.
Melchior-Becker A; Dai G; Ding Z; Schäfer L; Schrader J; Young MF; Fischer JW
J Biol Chem; 2011 May; 286(19):17365-75. PubMed ID: 21454527
[TBL] [Abstract][Full Text] [Related]
28. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response.
Huebener P; Abou-Khamis T; Zymek P; Bujak M; Ying X; Chatila K; Haudek S; Thakker G; Frangogiannis NG
J Immunol; 2008 Feb; 180(4):2625-33. PubMed ID: 18250474
[TBL] [Abstract][Full Text] [Related]
29. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction.
van Nieuwenhoven FA; Turner NA
Vascul Pharmacol; 2013 Mar; 58(3):182-8. PubMed ID: 22885638
[TBL] [Abstract][Full Text] [Related]
30. TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities.
Frangogiannis NG
Expert Opin Ther Targets; 2024; 28(1-2):45-56. PubMed ID: 38329809
[TBL] [Abstract][Full Text] [Related]
31. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction.
Dobaczewski M; Bujak M; Li N; Gonzalez-Quesada C; Mendoza LH; Wang XF; Frangogiannis NG
Circ Res; 2010 Aug; 107(3):418-28. PubMed ID: 20522804
[TBL] [Abstract][Full Text] [Related]
32. The immune system and cardiac repair.
Frangogiannis NG
Pharmacol Res; 2008 Aug; 58(2):88-111. PubMed ID: 18620057
[TBL] [Abstract][Full Text] [Related]
33. Macrophages in myocardial infarction.
Kubota A; Frangogiannis NG
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1304-C1324. PubMed ID: 36094436
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction.
Staufenberger S; Jacobs M; Brandstätter K; Hafner M; Regitz-Zagrosek V; Ertl G; Schorb W
J Cell Physiol; 2001 Jun; 187(3):326-35. PubMed ID: 11319756
[TBL] [Abstract][Full Text] [Related]
35. Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart.
Huang S; Chen B; Su Y; Alex L; Humeres C; Shinde AV; Conway SJ; Frangogiannis NG
J Mol Cell Cardiol; 2019 Jul; 132():84-97. PubMed ID: 31085202
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiology of Myocardial Infarction.
Frangogiannis NG
Compr Physiol; 2015 Sep; 5(4):1841-75. PubMed ID: 26426469
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
Yang R; Song Z; Wu S; Wei Z; Xu Y; Shen X
Atherosclerosis; 2018 Dec; 279():23-31. PubMed ID: 30399463
[TBL] [Abstract][Full Text] [Related]
38. Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction.
Carlson S; Trial J; Soeller C; Entman ML
Cardiovasc Res; 2011 Jul; 91(1):99-107. PubMed ID: 21357194
[TBL] [Abstract][Full Text] [Related]
39. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
40. The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation.
Shao Z; Nazari M; Guo L; Li SH; Sun J; Liu SM; Yuan HP; Weisel RD; Li RK
J Cell Mol Med; 2015 Dec; 19(12):2751-62. PubMed ID: 26471858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
